Effects of Listening to Binaural Beats on Anxiety and Pain Scores in Males Undergoing Cystoscopy and Stent Removal
NCT ID: NCT04595344
Last Updated: 2021-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
352 participants
INTERVENTIONAL
2019-07-08
2020-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy
NCT02725281
Brainwave Entrainment During Emergence
NCT05736510
The Effect of Vagus Nerve Stimulation on Lower Limb Muscle Strength and Balance in Nonelite Athletes
NCT06985043
The Effect Of Transcutaneous Auricular Vagus Nerve Stimulation On Sports Performance And Physiological Parameters
NCT04768738
Use of Binaural Beats for Colonoscopy
NCT04372511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Binaural beats have been recommended to reduce anxiety levels and the perception of pain in many treatment modalities.hey were discovered by Dove in 1841 and described in detail by Oster in 1973. Binaural beats are resulted from exposing each ear to two sounds which have steady intensities with different frequencies. A single tone with a midway frequency between the carrier tones is perceived. This frequency also waxes and wanes in amplitudes at a rate equal to the difference between the carrier tones It has been suggested that the human brain alters its dominant wave frequency toward that of the frequency of external stimuli to synchronize neural activity with stimuli from binaural beats.
METHOD
Ethics statement and participant selection
The study was approved by the institutional review board (Approval number and date: 16/15 - 04/07/2019 ). Male patients aged ≥ 18 y with negative urine culture, at least formal schooling (1-8 y of education) who had undergone local DC for various reasons (e.g., hematuria, carcinoma suspicion, follow-up for bladder cancer, and screening of the urethra or prostate) or unilateral USR were included in the study. Informed consent was provided by all the patients who accepted to participate in the study.
The exclusion criteria were patients who had a hearing or vision problems, neurological deficits, mental retardation, a history of chronic pelvic pain syndrome, history of previous DC or USR procedures, antidepressant use, or analgesia use 24 h before the procedure. Patients who underwent a bilateral USR procedure (for USR patients), required additional manipulations of the lower urinary tract (e.g., urethral dilation or biopsies), declined to participate, failed to complete the questionnaires, or could not tolerate the intervention were also excluded from the study.
Randomization, sample size, procedures, interventions, measurement of anxiety levels and pain scores
This was a prospective randomized, non-blinded and placebo-controlled study. After initial exclusions, patients were allocated to the study using the block randomization method. Two main groups were created according to the procedure applied: a DC group (DCG) and a USR group (USRG). The patients in the DCG were divided into three subgroups, according to the intervention applied: DCG-1, patients listened to binaural beats; DCG-2, patients listened to classical music; and DCG-3, patients wore headphones but were not exposed to audio (control group). The USRG was also divided into three subgroups, according to the intervention applied: USRG-1 patients listened to binaural beats; USRG-2 patients listened to classical music; and USRG-3 patients wore headphones but were not exposed to audio (control group). A power analysis indicated a minimum of 62 patients were required in each DCG to have power (1-β) of 0.90 at an alpha value of 0.05, with an effect size of 0.265. A minimum of 41 patients was required in each USRG to have power (1-β) of 0.90 at an alpha value of 0.05 with an effect size of 0.326. The sample sizes of the groups were calculated using the G-power 3.1 (Kiel, Germany).
The STAI is a questionnaire used for measuring anxiety.20 The STAI is often employed to determine an individual's emotional status before surgical interventions. It consists of 20 questions, and STAI scores range from 20 to 80. Higher STAI scores indicate increased anxiety levels. In this study, we used the Turkish validation of the STAI questionnaire to evaluate the patients' anxiety scores.21 Before the DC and USR procedures, the patients who accepted to participate in the study were asked to complete the STAI questionnaire and a nurse recorded the score of each patient (initial STAI: STAI-I). All the patients then put on headphones. For 10 min before the interventions, the patients in DCG-1 and USRG-1 listened to binaural beats, those in DCG-2 and USRG-2 listened to classical music and those in DCG-3 and USRG-3 sat in a quiet room with headphones on but no audio playing. The binaural beats were produced using a software program (Audacity®, version win. 2.3.2, 2019 Audacity Team) at frequency of 10 Hz (a tone of 200 Hz in the right ear and a tone of 210 Hz in the left ear). The binaural beats that the patients in DCG-1 and USRG-1 listened to were "pure" frequencies, with no background music or waves. The classical music that those in DCG-2 and USRG-2 listened to was Mozart's 40th Symphony. The audio headphones used in the DCGs and USRGs were wireless stereo headphones (Sony WH-CH510; Sony Corporation, U.S.). The patients who could not tolerate the interventions were also recorded. After the interventions, the STAI scores of the patients were measured again and recorded. (Terminal STAI: STAI-T). Delta anxiety score is recorded as STAI-I score minus STAI-T score (delta STAI: STAI-D).
The genital area was disinfected with povidone-iodine, and 10 ml of 2% lidocaine jelly was instilled intraurethrally and the penis was clamped approximately 5 min for local anesthesia before the procedures. We used a 17 F video flexible cystoscope for DCG procedure (Hawk GmbH, China) and 17 F rigid cystoscope (Stema GmbH, Germany) with 30 ͦ telescope (Karl Storz GmbH, Germany) for USR procedure. Semi-rigid forceps were used when performing USR. During the DC and USR procedures, the same interventions before the procedures were applied to the patients again. The VAS is a common tool in which patients score their pain level on a scale between 0 and 10.22 In this study, we also used the VAS to evaluate the patients' pain scores. After the procedures, the duration of the procedures and VAS scores 20 of the patients were also recorded. The duration of each procedure was calculated as the time between the entry and exit of the cystoscopy device into the urethral meatus.
Statistical Analysis
The Statistical analysis was made using IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, NY). The assumptions of normality were evaluated by the Shapiro-Wilk test. To determine differences between groups, One-way ANOVA test was used for parametric variables and Kruskal Wallis test was used for non-parametric variables. Bonferroni-Dunn test was used as a post-hoc test for significant cases. Pearson chi-square test and Fisher's exact test were used to compare the categorical variables between the groups while Bonferroni-Dunn test was also used as a post-hoc test for significant cases. A p value of \< 0.05 was considered statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic cystoscopy , Binaural beat group
patients listened to binaural beats
Listening to Pure Binaural Beats
The patients in DCG ((binaural beat group) ) and USRG (binaural beat group) listened to binaural beats.The binaural beats were produced using a software program (Audacity®, version win. 2.3.2, 2019 Audacity Team) at frequency of 10 Hz (a tone of 200 Hz in the right ear and a tone of 210 Hz in the left ear). The binaural beats that the patients in DCG-1 and USRG-1 listened to were "pure" frequencies, with no background music or waves.
Diagnostic cystoscopy, Classical music group
patients listened to classical music
Listening to classical music
The patients in DCG (classical music group) and USRG (classical music group) listened to classical music.The classical music that those in DCG-2 and USRG-2 listened to was Mozart's 40th Symphony.
Diagnostic cystoscopy , Placebo group
patients no audio only headphones
No audio only headphone
The patients in DCG (placebo group) and USRG (placebo group) sat in a quiet room with headphones on but no audio playing
Ureteral stent removal, Binaural beat group
patients listened to binaural beats
Listening to Pure Binaural Beats
The patients in DCG ((binaural beat group) ) and USRG (binaural beat group) listened to binaural beats.The binaural beats were produced using a software program (Audacity®, version win. 2.3.2, 2019 Audacity Team) at frequency of 10 Hz (a tone of 200 Hz in the right ear and a tone of 210 Hz in the left ear). The binaural beats that the patients in DCG-1 and USRG-1 listened to were "pure" frequencies, with no background music or waves.
Ureteral stent removal ,Classical music group
patients listened to classical music
Listening to classical music
The patients in DCG (classical music group) and USRG (classical music group) listened to classical music.The classical music that those in DCG-2 and USRG-2 listened to was Mozart's 40th Symphony.
Ureteral stent removal, Placebo group
patients no audio only headphones
No audio only headphone
The patients in DCG (placebo group) and USRG (placebo group) sat in a quiet room with headphones on but no audio playing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Listening to Pure Binaural Beats
The patients in DCG ((binaural beat group) ) and USRG (binaural beat group) listened to binaural beats.The binaural beats were produced using a software program (Audacity®, version win. 2.3.2, 2019 Audacity Team) at frequency of 10 Hz (a tone of 200 Hz in the right ear and a tone of 210 Hz in the left ear). The binaural beats that the patients in DCG-1 and USRG-1 listened to were "pure" frequencies, with no background music or waves.
Listening to classical music
The patients in DCG (classical music group) and USRG (classical music group) listened to classical music.The classical music that those in DCG-2 and USRG-2 listened to was Mozart's 40th Symphony.
No audio only headphone
The patients in DCG (placebo group) and USRG (placebo group) sat in a quiet room with headphones on but no audio playing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* negative urine culture
* at least formal schooling (1-8 y of education)
Exclusion Criteria
* neurological deficits
* mental retardation
* history of chronic pelvic pain syndrome
* history of previous DC or USR procedures
* antidepressant use or analgesia use 24 h before the procedure
* decline to participate
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Antalya Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmut Taha Olcucu
Asst. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmut Taha MO Ölçücü
Role: PRINCIPAL_INVESTIGATOR
Antalya Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antalya Training and Research Hospital
Antalya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.